Here are the Form 4 insider transactions from Vogenx Inc (VOGX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow VOGX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VOGX filings page.
Vogenx, Inc. (VOGX) Chief Scientific Officer, director and 10% owner William Wilkison received an option award covering 155,000 shares of common stock, with an exercise price of $20.053 per share and an expiration date of October 2, 2031. The options vest over three years in annual installments of 51,666 shares on October 2, 2027, 51,667 shares on October 2, 2028, and 51,667 shares on October 2, 2029, subject to continued service through each vesting date.
Vogenx, Inc. director Kenneth John Toombs received a grant of stock options covering 50,000 common shares on October 2, 2026, with an exercise price of $18.23 per share and an expiration date of October 2, 2036. The options vest in three annual installments: 16,666 shares on October 2, 2027, 16,667 shares on October 2, 2028, and 16,667 shares on October 2, 2029, subject to continued service through each vesting date.
Vogenx, Inc. director Peter Pieraccini received a direct award of 50,000 stock options to acquire common stock on October 2, 2026. The options have an exercise price of $18.23 per share and expire on October 2, 2036. They vest in three annual installments, subject to his continued service through each vesting date. Pieraccini's reported direct option position after the award was 50,000 options.
Vogenx, Inc. (VOGX) granted Chief Executive Officer James Green 155,000 stock options on October 2, 2026, with an exercise price of $20.053 per share and an expiration date of October 2, 2031. The options vest in three annual installments covering 51,666 shares on October 2, 2027, 51,667 shares on October 2, 2028, and 51,667 shares on October 2, 2029, subject to his continued service through each vesting date.
Vogenx, Inc. (VOGX) reported that Chief Financial Officer Steven R. Delmar received a grant of 155,000 stock options on October 2, 2026, covering 155,000 shares of common stock. The options have an exercise price of $18.23 per share and expire October 2, 2036. They vest in three annual installments, subject to continued service through each vesting date.
Vogenx, Inc. director Timothy Boris was granted 50,000 stock options on October 2, 2026, with an exercise price of $18.23 per share and an expiration date of October 2, 2036. His reported directly held position after the grant was 50,000 options. The options vest in three equal annual installments of 33.33%, subject to his continued service through each vesting date.